HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RIFM Prez Ladd Smith Leaves RIFM A More “Businesslike” Institute

This article was originally published in The Rose Sheet

Executive Summary

In an interview with “The Rose Sheet,” Research Institute for Fragrance Materials President Ladd Smith discusses how the organization has grown and become more transparent over the 13 years of his tenure. Smith announced his retirement in November.

You may also be interested in...



In Brief

At its annual FDA Cosmetic Regulatory Workshop, ICMAD encourages members to support new cosmetics safety legislation launched Apr. 18 by Rep. Leonard Lance, R-N.J. Additionally, RIFM adds a new president, Dr. David K. Wilcox, and FDA names Walter Harris COO.

People In Brief

Evelyn H. Lauder dies at age 75. Kiss My Face CEO spot goes to Steve Michaelson, former chief marketing officer of Supervalu and senior VP of Wegmens. RIFM President Ladd Smith announces his retirement. More people news.

Euromonitor: Value Shopping, Gender-Blurring Among Top Consumer Trends For 2106

A new report from market-research firm Euromonitor International suggests that global consumption in the coming year will see a blend of established, new and counter trends, challenging the way consumers live and shop. Within beauty, marketers may seize on the trends of value shopping, gender-blurring and embracing of aging to reach discriminating consumers in 2016.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017897

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel